Increased Risk Of Death In Patients Who Stop Using Statins After Stroke

Patients who stop taking cholesterol-lowering drugs within a year of surviving a stroke had a two-fold increased risk of death, researchers reported. Statins can benefit patients who have suffered an ischemic stroke (caused by a clot). However, stroke survivors often stop taking these drugs — an issue previously not studied in a clinical setting, said Furio Colivicchi, M.D., lead study author.

"To the best of our knowledge, this is the first evidence linking discontinuation of statin therapy to increased death rates in stroke survivors who have no other clinical evidence of heart disease," he and colleagues wrote.

The observational study ran for four-and-a-half years. Researchers identified 631 consecutive stroke survivors (322 men and 309 women, average age 70 years). None had any other major illness, including heart disease. All patients were discharged from the hospital with orders to take a drug regimen including statin therapy.

Trained nurses interviewed the patients and researchers examined their primary care physicians’ records for 12 months after their stroke. Researchers recorded the date and possible reasons for any cardiovascular drug discontinuation.

By the end of the study, 38.9 percent of the patients — 246 patients — had stopped taking statins. The average time to discontinuation was 48.6 days.

Seventy-one patients (28.8 percent) cited mild side effects, the most common of which was indigestion. In the other 175 cases (71.2 percent), neither the patient nor the primary care physician could give specific medical reasons for discontinuation.

"Because medication costs are covered by the Italian National Health Service, except for a small co-pay, cost cannot be related to these patients discontinuing their prescribed therapy," said senior author Carlo Caltagirone, M.D., Scientific Director of Santa Lucia Foundation. "In these studies the specific reasons for discontinuation are usually unknown, and they are difficult to analyze. However, contributing factors are probably related to patients’ and their healthcare providers’ behavior and beliefs, and probably also to features of the healthcare system itself."

Compared to the entire study group, patients who stopped taking the statins were older (71.4 vs. 69.5, on average) and more often female. Patients were less likely to stop taking the statins if they had diabetes or a previous stroke.

During the study, 116 patients died. Eighty percent of these deaths were attributed to cardiovascular causes. Statistical analysis determined that discontinuing statin therapy was independently and significantly associated with increased risk of death from any cause. Patients who had stopped taking statins within a year of stroke were more than twice as likely to die (2.78 hazard ratio) than others in the study group.

"Patients who stop taking the statins have a significantly increased chance of death in the first year after their stroke — and the earlier they stop, the higher the risk they face," Colivicchi said. "In fact, the risk factors for the association between statin discontinuation and death gradually decreased with time. Effective clinical strategies are needed to bring out a significant increase in patients who maintain their drug therapies." Researchers said future studies should also evaluate whether interventions designed to improve patients’ self-care behaviors and lifestyles might also improve the percentage of patients who continue their medication.
Stroke September 2007

================================

DID YOU KNOW:
PAD patients have a substantially increased risk of dying 10 years early: And that asymptomatic PAD patients are as much at risk as symptomatic ones. "This is the first time, in such a big study, that we have found no difference in mortality between asymptomatic and symptomatic PAD patients. We learned that PAD patients are usually asymptomatic, and we say in the guidelines that symptomatic patients have to be treated in a different way, but now we need to change the guidelines."
See This Week’s Item #1

================================

.PLEASE CLICK HERE TO UPDATE YOUR PROFILE!!! https://www.diabetesincontrol.com/surveys/index.php